Mechanism of emergence of hepatitis B virus escape variants: Approaches to prevention

Journal of Viral Hepatitis

Volumn 5, Issue SUPPL. 2, 1998, Pages 31-36

  Thomas, H C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Hepatitis B; Mutants; Vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIGENICITY; CONFERENCE PAPER; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS ENVELOPE; VIRUS HEPATITIS;

DRUG DESIGN; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MUTATION;

EID: 0031770168     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.0050s2031.x     Document Type: Article

References (24)

1. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in The Gambia. N Engl J Med 1995; 332: 1065.
2. Bertoletti A, Ferrari C, Fiaccadori F et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 1991; 88: 10445.
3. Penna A, Chisari FV, Bertoletti A et al. Cytotoxic T lymphocytes recognise an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565-72.
4. Waters JA, O'Rourke S, Schlicht HJ, Thomas HC. Cytotoxic T cell responses in patients with chronic hepatitis B virus infection undergoing HBe antigen/antibody seroconversion. Clin Exp Immunol 1995; 102: 314-20.
5. Pignatelli M, Waters JA, Lever AM, Iwarson S, Gerety RJ. Thomas HC. Cytotoxic T cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. J Hepatol 1987; 4: 15-21.
6. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 3442.
7. Thomas HC. Immunological mechanisms in chronic hepatitis B virus infection. Hepatology 1982; 2: 116S-119S.
8. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of HBe antigen in patients with chronic HBV infection. Lancet 1989; ii: 588-91.
9. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 1981; 305: 1067-73.
10. Twu JS, Lee C, Lin P, Schoemer RH. Hepatitis B virus suppresses expression of human Beta interferon. Proc Natl Acad Sci USA 1988; 85: 252-6.
11. Lemon SM, Murphy PC, Shields PA et al. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection; evidence for genetic recombination. J Virol 1990; 65: 2056-65.
12. Nowak MA, May RM, Phillips RE et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995; 375: 606-11.
13. Brown SE, Howard CR, Zuckerman AJ, Steward MW. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 1984; ii: 184-7.
14. Chen YC, Delbrook K, Dealwis C, Mimms L, Mushawar IK, Mandecki W. Discotinuous epitopes of hepatitis B surface antigen derived from a filamentous phage library Proc Natl Acad Sci USA 1996; 93: 1997-2001.
15. LeBouvier GL, McCollum RW, Hierholzer WJJ, Irwin GR, Krugman S, Giles JP. Subtypes of Australia antigen and hepatitis B virus. JAMA 1972; 222: 928-930.
16. Bancroft WH, Mundon FK, Russell PK. Detection of additional antigenic determinants of hepatitis B antigen. J Immunol 1972; 109: 842-8.
17. Ashton-Rickardt PG, Murray K. Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination. J Med Virol 1989; 29: 916-203.
18. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K et al. Mutations within the s gene of hepatitis B virus transmitted from mothers to babies immunised with hepatitis B imune globulin and vaccine. Paediatric Res 1992; 32: 264-8.
19. Zanetti AR, Tanzi E, Manzillo G et al. Hepatitis B variant in Europe (Letter). Lancet 1988; ii: 1132-3.
20. Carman WF, Zanetti AR, Karayiannis P. Vaccine induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.
21. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991; 13; S105-S107.
22. Fujii H, Moriyarna K, Sakamoto N et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophysics Res Comms 1992; 184: 1152-7.
23. McMahon G, Ehrlich PH, Moustafa ZA et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757-66.
24. Iwarson S, Tabor E, Thomas HC, Snoy P, Geretz RJ. Protection against hepatitis B virus infection by immunisation with hepatitis B core antigen. Gastroenterology 1985; 88: 763-7.